We are live on ! Find out more
LIM

Lagoda Investment Management Portfolio holdings

AUM $182M
1-Year Est. Return 58.16%
This Fund
S&P 500
This Quarter Est. Return
+17.82%
1 Year Est. Return
+58.16%
3 Year Est. Return
+249.95%
5 Year Est. Return
+282.35%
10 Year Est. Return
+2,138.78%
AUM
$333M
AUM Growth
+$64.3M
Cap. Flow
+$25.4M
Cap. Flow %
7.64%
Top 10 Hldgs %
70.78%
Holding
29
New
1
Increased
14
Reduced
8
Closed

Top Buys

Rank Stock Value
1
MON
Monsanto Co
MON
+$10.4M
2
UI icon
Ubiquiti
UI
+$5.96M
3
VNRX icon
VolitionRx Ltd
VNRX
+$5.07M
4
TTOO
T2 Biosystems, Inc
TTOO
+$3.02M
5
DMRC icon
Digimarc Corp
DMRC
+$1.76M

Sector Composition

Rank Sector Weight
1 Healthcare 52.25%
2 Technology 20.9%
3 Communication Services 12.14%
4 Financials 9.29%
5 Materials 5.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
26
AbbVie
ABBV
$465B
$31K 0.01%
491
ABT icon
27
Abbott
ABT
$177B
$27K 0.01%
640
PSX icon
28
Phillips 66
PSX
$106B
$16K ﹤0.01%
197
GSK icon
29
GSK
GSK
$100B
$8K ﹤0.01%
139

Similar funds

Lagoda Investment Management's Q3 2016 Portfolio in Review

As of Q3 2016, Lagoda Investment Management held 29 positions worth $333M, up 24% from $268M the previous quarter. Its ten largest holdings account for 71% of the portfolio.

Lagoda Investment Management deployed $25.4M of net new capital in Q3 2016, opening 1 new position and adding to 14 existing holdings. Its largest new stake was Berkshire Hathaway Class B: 1,400 shares worth $202K.

By sector, the portfolio is most concentrated in Healthcare at 52% of assets, down from 54% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was Merrimack Pharmaceuticals, Inc., an estimated $1.97M trimmed.

  • Lagoda Investment Management's largest Q3 2016 buy was Berkshire Hathaway Class B: 1,400 shares worth $202K.
  • Lagoda Investment Management added most to Monsanto Co in Q3 2016, an estimated $10.4M increase.
  • Lagoda Investment Management's biggest Q3 2016 reduction was Merrimack Pharmaceuticals, Inc., cutting an estimated $1.97M.
  • Lagoda Investment Management's ten largest holdings make up 71% of its $333M portfolio in Q3 2016.
  • Lagoda Investment Management opened 1 new position and closed 0 in Q3 2016.
  • Lagoda Investment Management's portfolio value rose 24% quarter-over-quarter to $333M.

Based on Lagoda Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.